Impact of the GSTA1 Gene Polymorphism on Clinical Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myeloid Leukemia

The occurrence of complications following HSCT of leukemic patients is highly variable and dependent on a multitude of host, donor, and treatment factors. Identifying important genetic variables will allow for better prediction of HSCT-related outcomes.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Mostafaf Mohammed Saleh, Essam El Beih, Raafat Abdel-Fattah, Hosam Kamel, Alaa El Haddad, Omar Fahmy, Mohamed Samra, Gamal Fathy, Gamal Ebid, Eman Radwan, Azza Kamel Source Type: research